Our differential expression analysis of CDK2 and CDK4 expression profiles revealed that both CDK2 and CDK4 are overexpressed in breast cancer tumors compared to adjacent normal tissues (Figure 1A). This evidence concerns the gene CDK4 and breast cancer.